4

OWNERSHIP DOCUMENT

Company: Bolt Biotherapeutics, Inc.
Filed: February 9, 2021
Period of Report: February 9, 2021
Accession Number: 0001104659-21-016806

View Document ↗ View on SEC.gov ↗